
Essential zzso zzso is a disease associated with an elevated risk of zzso This study evaluated the efficacy and safety of zzso zzso in the long-term control of zzso patients who had, at diagnosis, one or more of the following currently known risk factors for zzso or zzso zzso zzso age zzso 60 years, history of zzso or zzso zzso zzso zzso zzso From 1978 to 2000, with a median follow-up of 10 years, 118 previously zzso high-risk zzso patients zzso age 62 years, range zzso were treated with zzso at the starting dose of zzso zzso All patients reached a zzso count zzso zzso zzso and zzso achieved a zzso count zzso zzso zzso During zzso 13 patients had zzso with a 10-year cumulative risk of zzso Acute zzso zzso zzso and solid zzso occurred in three, two and seven patients with a 10-year cumulative risk of zzso zzso and zzso zzso zzso survival at 20 years was zzso and the standardized mortality ratio was zzso zzso zzso zzso not statistically different from the general population zzso zzso zzso Age was associated with a higher risk of death zzso zzso zzso and zzso zzso zzso zzso The duration of zzso treatment did not correlate with the occurrence of second zzso This study, with a median follow-up of 10 years, demonstrates that zzso is effective and well zzso The low cumulative 10-year risk of zzso zzso and solid zzso indicates that zzso is an adequate treatment for patients with high risk zzso 

